HBV Reactivation in Immunosuppressed Patients: Screening, Prevention, and Management Including Solid Organ Transplant Recipients
2025
Philip Vutien | Mindie H. Nguyen
Hepatitis B virus (HBV) infection remains a global health challenge, affecting over 254 million individuals chronically and contributing significantly to cirrhosis, liver failure, and hepatocellular carcinoma. Despite advancements in antiviral therapy, HBV reactivation remains a critical concern, particularly in immunosuppressed individuals, including non-transplant patients undergoing immunosuppressive therapy and solid organ transplant recipients. This review provides screening and management strategies for HBV reactivation in these populations.
显示更多 [+] 显示较少 [-]AGROVOC关键词
书目信息
出版者
MDPI AG
其它主题
Hepatitis b; De novo infection; Chronic hepatitis b infection
语言
英语
2025-04-17
2026-01-23
DOAJ